The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSDL.L Regulatory News (SDL)

  • There is currently no data for SDL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

1 Oct 2020 12:20

RNS Number : 8316A
Nplus1 Singer Capital Markets Ltd
01 October 2020
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Nplus1 Singer Capital Markets Limited

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

SDL PLC

 

(c) Name of the party to the offer with which exempt principal trader is connected:

SDL PLC

(d) Date dealing undertaken:

30 September 2020

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

YES

 

If YES, specify which:

 

RWS Holdings Plc

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 1P

 

 

Purchase

 

30,879

 

682.8p

 

678p

 

 

ORD 1P

 

 

Sale

 

31,955

 

700p

 

 

677.8p

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

01 October 2020

Contact name:

Sarah-Rose Perry, Jennifer Bentick

Telephone number:

020 7496 3093

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERMZMGGMMLGGZM
Date   Source Headline
15th May 20174:46 pmRNSHolding(s) in Company
15th May 20178:35 amRNSHolding(s) in Company
5th May 201712:34 pmRNSAnnual Financial Report
3rd May 20178:13 amRNSHolding(s) in Company
27th Apr 201710:45 amRNSAGM Statement
21st Apr 20179:33 amRNSDirector/PDMR Shareholding
20th Apr 201711:30 amRNSDirector/PDMR Shareholding
20th Apr 201711:27 amRNSTotal Voting Rights
20th Apr 20177:00 amRNSDisposal of Social Intelligence
5th Apr 20175:45 pmRNSHolding(s) in Company
4th Apr 20176:05 pmRNSHolding(s) in Company
21st Mar 20174:25 pmRNSApplication for Blocklisting
21st Mar 20174:11 pmRNSIssue of Equity
16th Mar 201711:10 amRNSDirector/PDMR Shareholding
8th Mar 20178:01 amRNSCompletion of disposal
7th Mar 20172:44 pmRNSDividend Declaration
7th Mar 20177:00 amRNSFinal Results
28th Feb 20177:00 amRNSTotal Voting Rights
24th Feb 20173:10 pmRNSHolding(s) in Company
14th Feb 20177:00 amRNSAppointment of Chief Product Officer
31st Jan 20174:34 pmRNSHolding(s) in Company
30th Jan 20177:15 amRNSDisposal of Fredhopper
20th Jan 20177:00 amRNS2016 Year-end Trading Update
5th Jan 20173:24 pmRNSBlock listing Interim Review
29th Dec 20163:52 pmRNSHolding(s) in Company
7th Dec 20163:25 pmRNSDirector/PDMR Shareholding
6th Dec 20167:00 amRNSCapital Markets Presentation
15th Nov 201610:11 amRNSHolding(s) in Company
3rd Nov 20167:00 amRNSDisposal of Campaigns business
2nd Nov 20164:26 pmRNSHolding(s) in Company
31st Oct 201610:07 amRNSHolding(s) in Company
21st Oct 20163:17 pmRNSHolding(s) in Company
5th Oct 20163:20 pmRNSTotal Voting Rights
22nd Sep 20169:51 amRNSHolding(s) in Company
5th Sep 201610:42 amRNSTotal Voting Rights
2nd Sep 201610:30 amRNSHolding(s) in Company
26th Aug 201611:11 amRNSHolding(s) in Company
23rd Aug 201610:29 amRNSHolding(s) in Company
18th Aug 20165:16 pmRNSHolding(s) in Company
9th Aug 20163:56 pmRNSTotal Voting Rights
4th Aug 20162:30 pmRNSHolding(s) in Company
3rd Aug 20163:24 pmRNSDirector/PDMR Shareholding
2nd Aug 20167:00 amRNSHalf-year Report
19th Jul 20162:05 pmRNSNotice of Results
5th Jul 20169:24 amRNSTotal Voting Rights
5th Jul 20169:23 amRNSHolding(s) in Company
1st Jul 201612:23 pmRNSDirector Declaration
22nd Jun 201611:23 amRNSDirector/PDMR Shareholding
8th Jun 20169:40 amRNSDirectorate Change
6th Jun 20168:00 amRNSAppointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.